Chronic Kidney Disease in Dogs: Welfare Management

Canine Chronic Kidney Disease and Welfare

Chronic kidney disease (CKD) is among the most common and welfare-significant conditions affecting older dogs, particularly in small to medium breeds. With early detection and appropriate management, dogs with CKD can maintain good quality of life for extended periods — making this a condition where veterinary partnership is highly rewarding.

Understanding CKD Staging

IRIS (International Renal Interest Society) staging classifies CKD by creatinine, SDMA (symmetric dimethylarginine), and proteinuria:

• Stage 1: Renal markers within normal range but structural kidney damage present; treat underlying cause; monitor
• Stage 2: Mild azotaemia; often no clinical signs; dietary management recommended
• Stage 3: Moderate azotaemia; clinical signs begin (PU/PD, weight loss, reduced appetite); intensive management required
• Stage 4: Severe azotaemia; uraemia; significant welfare compromise; quality of life assessment essential

Welfare Impacts

• Uraemic toxin accumulation causes nausea, anorexia, and malaise in advanced stages
• Hypertension causes headache-like effects and risks retinal detachment (sudden blindness)
• Anaemia of CKD causes fatigue and weakness
• Metabolic acidosis causes lethargy and discomfort
• Phosphate retention causes bone disease and itch (uraemic pruritus)

Management Strategies

• Renal diet: Restricted phosphorus, moderate protein restriction; wet food preferred for hydration; major impact on progression rate
• Hydration: Encouraging water intake; wet food; SC fluids at home for some Stage 3-4 dogs
• Phosphate binders: Aluminium hydroxide or calcium carbonate to reduce phosphate absorption
• ACE inhibitors/ARBs: Reduce proteinuria and slow progression in proteinuric CKD
• Anti-nausea: Maropitant, omeprazole for nausea and gastric hyperacidity
• Erythropoiesis-stimulating agents: For anaemia management in advanced CKD
• Antihypertensives: Amlodipine for hypertension management
• Regular monitoring: IRIS staging re-evaluation; blood pressure; proteinuria

Quality of Life Assessment

As CKD progresses, honest quality of life assessment using validated tools (HHHHHMM scale) guides end-of-life decisions. Good appetite, social engagement, and comfortable mobility are positive indicators; persistent vomiting, extreme weight loss, and inability to rest comfortably are negative.

Key Takeaways

CKD management significantly extends comfortable life in affected dogs. Early detection through routine blood screens in older dogs, IRIS staging, renal diet, and targeted medical management are the foundations of good CKD welfare care.